Skip to main content

Table 1 Patient characteristics

From: Efficacy of tonsillectomy for the treatment of immunoglobulin A nephropathy recurrence after kidney transplantation

  Tonsillectomy (n = 5) No tonsillectomy (n = 7) p
Recipient gender (M/F) 2/3 6/1 0.10
Recipient age at transplantation (mean ± SD) 33.7 ± 9.7 36.6 ± 8.6 0.75
Donor age at transplantation (mean ± SD) 57.7 ± 15.5 53.1 ± 17.1 1.00
Duration of pre-transplant dialysis (months) 41.3 ± 42.1 9.6 ± 3.6 0.10
Living/deceased 5/0 6/1 1.00
ABO compatible/incompatible 3/2 7/0 0.15
Immunosuppressant use (CsA/FK) 3/2 6/1 0.52
SCr at recurrence (mg/dl) 1.15 ± 0.28 1.29 ± 0.17 0.33
eGFR at recurrence (ml/min) 47.7 ± 14.6 39.1 ± 5.8 0.33
Urinary findings at recurrence
Hematuria 3/5 (60%) 4/7 (57%) 1.00
Proteinuria (g/g·Cr) 0.33 ± 0.52 0.07 ± 0.19 0.39
Use of RASI 5/5 (100%) 6/7 (85.7%) 1.00
Period between transplant and IgAN recurrence (months) 37.4 ± 25.7 31.8 ± 19.3 0.94
Median time between IgAN recurrence and tonsillectomy (months) 3.1(1.4 − 28.9)
Time between IgAN recurrence and the next protocol biopsy (months) 57.4 ± 10.1 61.4 ± 8.5 0.76
Follow-up period (months) 146.8 ± 30.1 193.6 ± 105.1 0.75